Medirom Healthcare Net Worth
Medirom Healthcare Net Worth Breakdown | MRM |
Medirom Healthcare Net Worth Analysis
Medirom Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Medirom Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Medirom Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Medirom Healthcare's net worth analysis. One common approach is to calculate Medirom Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Medirom Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Medirom Healthcare's net worth. This approach calculates the present value of Medirom Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Medirom Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Medirom Healthcare's net worth. This involves comparing Medirom Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Medirom Healthcare's net worth relative to its peers.
To determine if Medirom Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Medirom Healthcare's net worth research are outlined below:
| Medirom Healthcare is way too risky over 90 days horizon | |
| Medirom Healthcare appears to be risky and price may revert if volatility continues | |
| Medirom Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| Medirom Healthcare Technologies has 3.96 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Medirom to invest in growth at high rates of return. | |
| Medirom Healthcare Technologies has about 354.95 M in cash with (1.33 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 26.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Western Asset Investment Grade Defined Opportunity Trust Inc. Announces Monthly Dividend of 0.07 |
Medirom Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Medirom Healthcare Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medirom Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of May 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Follow Medirom Healthcare's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 15.88 M.Project Medirom Healthcare's profitablity
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.26) %, which entails that for every $100 of revenue, it lost $0.26.When accessing Medirom Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Medirom Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Medirom Healthcare's profitability and make more informed investment decisions.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medirom Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medirom Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medirom Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cohen Edward H over a year ago Disposition of 2500 shares by Cohen Edward H of Medirom Healthcare at 11.18 subject to Rule 16b-3 | ||
Cohen Edward H over a year ago Disposition of 2500 shares by Cohen Edward H of Medirom Healthcare at 9.78 subject to Rule 16b-3 |
Medirom Healthcare Earnings per Share Projection vs Actual
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.